The Viborg Vascular randomised screening trial

Back

ESC Premium Access

The Viborg Vascular randomised screening trial

Session: Hot Line: Late-Breaking Clinical Trials 2

Topic: Primary cardiovascular prevention: interventions and outcomes

Speaker: Professor J. Lindholt (Odense, DK)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Jes Lindholt

Odense University Hospital, Odense (Denmark)

2 presentations

0 follower

17 more presentations in this session

SPYRAL HTN OFF-MED Study

Speaker: Professor M. Boehm (Homburg, DE)

Access

Slides

Video

Discussant review: SPYRAL HTN OFF-MED Study

Speaker: Professor B. Williams (London, GB)

Access

Slides

Video

Panel discussion.

Access

Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE Trial

Speaker: Professor M. Ezekowitz (Philadelphia, US)

Discussant review:Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE Trial

Speaker: Professor J. Nielsen (Aarhus, DK)

Access the full session

Hot Line: Late-Breaking Clinical Trials 2

Speakers: Professor J. Lindholt, Professor M. Boehm, Professor B. Williams, Professor M. Ezekowitz, Professor J. Nielsen

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources